-
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12
Lifestyle Content
Technology
-
As “Disclosure” Dominates the Headlines, a Pastor Offers a Biblical Lens on the Lights in the Sky – “Light in the Darkness” by Bill Martin
-
PRV Tree Service Urges Austin TX Property Owners to Address Roof Clearance Before Branches Become Hazards
-
Arlington VA Family Lawyer Sheds Light On How Adultery Affects Spousal Support
-
New Book Confronts the Quiet Compromise Creeping Into Modern Christianity – “For Such a Time as Now” by Daryl Boyer
-
San Diego Boat Accidents Highlight Important Legal Steps for Injured Victims
Entertainment
-
Allstream Energy Partners, SEO Experts in Oil and Gas, Awarded Gas Processing OEM Agreement
-
World-Renowned Body Language Expert Mark Bowden Headlines INSPIRE Northwest 2026 in Wenatchee, WA
-
Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
-
USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
-
ASN Software Introduces New California CARS Act Dealer Updates
Health
-
RevOps job postings are outpacing hires so fast that one company is running the same search on two continents
-
The AI career premium: How AI skills are accelerating career paths
-
Banks made $3 billion from overdraft fees in just 6 months: Here’s how to avoid paying them
-
The life expectancy gap is putting a new focus on long-term financial planning
-
How to explain being a futures trader to your friends and family
